Fycompa (perampanel) is indicated for the adjunctive treatment of: partial-onset seizures (POS) with or without secondarily generalised seizures in patients from 4 years of age and older; primary generalised tonic-clonic (PGTC) seizures in patients from 7 years of age and older with idiopathic generalised epilepsy (IGE).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign Out
